KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Equity (2019 - 2025)

Historic Return on Equity for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to 0.41%.

  • Adaptive Biotechnologies' Return on Equity rose 4300.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 0.62% for FY2024, which is 400.0% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Return on Equity stood at 0.41% for Q3 2025, which was up 4300.0% from 0.66% recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Return on Equity peaked at 0.21% during Q1 2021, and registered a low of 0.84% during Q3 2024.
  • Moreover, its 5-year median value for Return on Equity was 0.44% (2022), whereas its average is 0.52%.
  • Per our database at Business Quant, Adaptive Biotechnologies' Return on Equity plummeted by -3600bps in 2024 and then skyrocketed by 4300bps in 2025.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Return on Equity stood at 0.33% in 2021, then decreased by -27bps to 0.42% in 2022, then crashed by -60bps to 0.67% in 2023, then dropped by -11bps to 0.75% in 2024, then soared by 45bps to 0.41% in 2025.
  • Its last three reported values are 0.41% in Q3 2025, 0.66% for Q2 2025, and 0.72% during Q1 2025.